13G REPORT

Company

Niagen Bioscience, Inc.

Filed

February 26, 2021

Accession Number

0001738071-21-000004

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →